Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management
Indexed incrossrefpubmed
Abstract
Alzheimer's disease (AD), is a neurodegenerative disorder that escalates with time, exerting a significant impact on physical and mental health and leading to death. The prevalence of AD is progressively rising along with its associated economic burden and necessitates effective therapeutic approaches in the near future. This review paper aims to offer an insightful overview of disease pathogenesis, current FDA-approved drugs, and drugs in different clinical phases. It also explores innovative formulations and drug delivery strategies, focusing on nanocarriers and long-acting medications (LAMs) to enhance treatment efficacy and patient adherence. The review also emphasizes preclinical evidence related to…
Citation impact
201
total citations
- FWCI
- 81.00
- Percentile
- 100%
- References
- 205
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Nanocarriers
- Disease
- Medicine
- Drug
- Intensive care medicine
- Drug development
- Drug delivery
- Pharmacology
No related works found for this paper.